This report describes the global market size for Montelukast from 019 to 2023 and its CAGR from 2019 to 2023. The report also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.
For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.
This report covers the following regions:
- North America
- South America
- Asia & Pacific
- Europe
- MEA
The key countries for each region are also included, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
For the competitor segment, the report includes global key players of Montelukast as well as some small players.
Companies Covered
- Teva
- Mylan
- Hikma
- Glenmark
- Sandoz
- Dr Reddy's
The information for each competitor includes:
- Company Profile
- Business Information
- SWOT Analysis
- Revenue, Gross Margin and Market Share
Types Segment
- Granule
- Tablet
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Teva
- Mylan
- Hikma
- Glenmark
- Sandoz
- Dr Reddy's